Kopal Garg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kopal Garg has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alan B. Cantor
Division of Hematology, Boston Children’s Hospital, Boston, MA
1 shared publication - Alan D. Michelson
Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA
1 shared publication - Anne Odonnell-Luria
Center for Genomic Medicine, Massachusetts General Hospital, Boston, USA
1 shared publication - Jeffrey M. Verboon
Fred Hutchinson Cancer Research Center
1 shared publication - Julia K. Goodrich
Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard
1 shared publication - Katherine R. Chao
Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, USA
1 shared publication
Latest Publications
- Open Access
- 15 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
Advances in genome sequencing have resulted in the identification of the causes for numerous rare diseases. However, many cases remain unsolved with standard molecular analyses. We describe a family presenting with a phenotype resembling inherited thrombocytopenia 2 (THC2). THC2 is generally caused by single nucleotide variants that prevent silencing of ANKRD26 expression during hematopoietic differentiation. Short-read whole-exome and genome sequencing approaches were unable to identify a causal variant in this family. Using long-read whole-genome sequencing, a large complex structural variant involving a paired-duplication inversion was identified. Through functional studies, we show that this structural variant results in a pathogenic gain-of-function WAC-ANKRD26 fusion transcript. Our findings illustrate how complex structural variants that may be missed by conventional genome sequencing approaches can cause human disease.
- 15 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Open AccessFamilial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
Advances in genome sequencing have resulted in the identification of the causes for numerous rare diseases. However, many cases remain unsolved with standard molecular analyses. We describe a family presenting with a phenotype resembling inherited thrombocytopenia 2 (THC2). THC2 is generally caused by single nucleotide variants that prevent silencing of ANKRD26 expression during hematopoietic differentiation. Short-read whole-exome and genome sequencing approaches were unable to identify a causal variant in this family. Using long-read whole-genome sequencing, a large complex structural variant involving a paired-duplication inversion was identified. Through functional studies, we show that this structural variant results in a pathogenic gain-of-function WAC-ANKRD26 fusion transcript. Our findings illustrate how complex structural variants that may be missed by conventional genome sequencing approaches can cause human disease.